Viktor Zarev

Viktor Zarev

InvestorPlace Contributor

Expertise: Science, Technology, Defense, and Medicine Stock Review

Education: BS in Biology from Baylor University, MS in Computer Science from Pace University

Viktor Zarev is a Freelance Writer at InvestorPlace.com, where he aims to elucidate and simplify the world of high-tech stocks and cryptocurrencies. To accomplish this, Viktor specializes in distilling the most pertinent and critical details for investors to focus on.

He also writes in-depth research scripts for defense documentaries on YouTube as well as creative direction and copywriting for game studios. He is also a supply chain specialist in the defense industry.

Viktor holds a BS in Global Health Biology from Baylor University, where he graduated on the Medical Entomology Research Track, studying flaviviruses and developing vector control methods. He is currently earning an MS in Computer Science from Pace University, focusing on artificial intelligence and machine learning.

Recent Articles

Shhh! 3 Secret 5G Stocks Flying Below Wall Street’s Radar

By Viktor Zarev, InvestorPlace Contributor

With the realization that the 5G rollout will become a continuous process, these three 5G stocks are primed to advance the industry.

Oil Darlings: 3 Global Oil Stocks to Buy Amid Rising Prices

By Viktor Zarev, InvestorPlace Contributor

Investors should keep an eye on these three global oil stocks to buy, if crude oil prices rise as a result of increasing conflict.

3 Overvalued Defense Stocks to Sell Before the 2024 Election

By Viktor Zarev, InvestorPlace Contributor

Here are three overvalued defense stocks to sell in the event of a major administration change in the United States.

Alarm Bells: 3 Overvalued Tech Stocks to Sell Before the AI Bubble Bursts

By Viktor Zarev, InvestorPlace Contributor

These are three overvalued tech stocks to sell in order to protect your portfolio from a potential AI bubble burst.

3 Healthcare Stocks to Buy Now: Q2 Edition

By Viktor Zarev, InvestorPlace Contributor

Between an aging population and increased government spending, investors should consider these three healthcare stocks to buy now.

Load More